Granahan Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.2M Buy
86,953
+14,951
+21% +$2.09M 0.5% 55
2025
Q4
$11.8M Buy
72,002
+2,131
+3% +$334K 0.51% 55
2025
Q3
$9.34M Sell
69,871
-65,175
-48% -$7.92M 0.38% 65
2025
Q2
$16.8M Buy
135,046
+33,849
+33% +$4.31M 0.68% 41
2025
Q1
$12.9M Sell
101,197
-6,218
-6% -$957K 0.64% 51
2024
Q4
$15.5M Buy
107,415
+19,160
+22% +$2.75M 0.65% 47
2024
Q3
$13.1M Buy
+88,255
New +$12.7M 0.52% 58
2024
Q2
Sell
-124,765
Closed -$22.9M 196
2024
Q1
$22.9M Sell
124,765
-4,921
-4% -$937K 0.81% 36
2023
Q4
$23.3M Sell
129,686
-3,072
-2% -$478K 0.77% 39
2023
Q3
$21.1M Sell
132,758
-18,014
-12% -$2.94M 0.75% 38
2023
Q2
$21.3M Buy
150,772
+39,632
+36% +$6.35M 0.66% 46
2023
Q1
$18.7M Buy
111,140
+3,474
+3% +$620K 0.57% 56
2022
Q4
$18.2M Buy
107,666
+40,344
+60% +$7.32M 0.56% 49
2022
Q3
$12.6M Sell
67,322
-56,100
-45% -$11.8M 0.41% 69
2022
Q2
$20M Buy
123,422
+99,947
+426% +$15.8M 0.68% 36
2022
Q1
$4.42M Buy
+23,475
New +$4.46M 0.11% 138
2021
Q3
Sell
-3,976
Closed -$794K 199
2021
Q2
$794K Sell
3,976
-32,552
-89% -$6.31M 0.01% 188
2021
Q1
$7.1M Buy
36,528
+9,847
+37% +$2.02M 0.15% 117
2020
Q4
$5.11M Sell
26,681
-103,269
-79% -$18.8M 0.11% 131
2020
Q3
$19.2M Sell
129,950
-37,281
-22% -$5.33M 0.65% 45
2020
Q2
$21.3M Sell
167,231
-35,883
-18% -$4.22M 0.77% 35
2020
Q1
$19.6M Sell
203,114
-38,552
-16% -$3.72M 1.06% 22
2019
Q4
$22.4M Sell
241,666
-1,022
-0.4% -$85.9K 1.03% 26
2019
Q3
$18.6M Sell
242,688
-13,067
-5% -$1.14M 1.02% 26
2019
Q2
$22M Sell
255,755
-22,041
-8% -$1.5M 1.09% 27
2019
Q1
$16.4M Buy
277,796
+11,994
+5% +$690K 0.88% 37
2018
Q4
$14M Sell
265,802
-1,514
-0.6% -$88.8K 0.99% 35
2018
Q3
$14.8M Buy
267,316
+89,157
+50% +$4.6M 0.8% 41
2018
Q2
$8.38M Buy
178,159
+19,230
+12% +$791K 0.5% 66
2018
Q1
$5.75M Buy
158,929
+129,230
+435% +$4.54M 0.42% 84
2017
Q4
$1.08M Buy
+29,699
New +$1.08M 0.08% 165

Other funds holding RGEN

Granahan Investment Management's RGEN Position: Q1 2026 in Review

Granahan Investment Management increased its Repligen (RGEN) stake by 21% in Q1 2026, buying an estimated $2.09M and bringing the position to 86,953 shares worth $10.2M. The position accounts for 0.5% of the portfolio, ranked #55.

Granahan Investment Management first reported a position in RGEN in Q4 2017 and has held it in 31 quarters since. The position peaked at $23.3M in Q4 2023. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Granahan Investment Management held 86,953 shares of Repligen worth $10.2M as of Q1 2026.
  • Granahan Investment Management bought 14,951 Repligen shares in Q1 2026, an estimated $2.09M.
  • Repligen made up 0.5% of Granahan Investment Management's portfolio in Q1 2026, its #55 holding.
  • Granahan Investment Management first reported a position in Repligen in Q4 2017 and has held it in 31 quarters since.
  • Granahan Investment Management's Repligen position peaked at $23.3M in Q4 2023.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Granahan Investment Management's 13F filing for Q1 2026, filed 15 May 2026.